Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia

NCT00096018 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: fludarabine phosphate
DRUG: thalidomide

Sponsor

Roswell Park Cancer Institute